UNDERSTANDING THE DRUG DEVELOPMENT/REVIEW PROCESS (1/2 Day)
UPCOMING DATES:
- TBA
Course Description:
Designed for life sciences professionals from all disciplines who require (or desire) a basic understanding of drug development from both an FDA and industry insider perspective.Utilizes a ‘backward planning’ perspective – focusing on drug development with maximum patient benefit and commercialization in mind.
Targeted for numerous life science disciplines, including:
- Clinical
- Regulatory
- Commercial
- Medical
- Legal
- Compliance
- Training
- Medical writers
- Communications
Topics include, but are not limited to:
- Drug Development phases and definition
- IND and NDA (BLA)
- FDA organizational structure – Centers, Offices, Divisions, etc
- Working with FDA (meetings, preparation and follow-up, expectations, interpersonal interactions)
- FDA internal interactions
- FDA external interactions: other regulatory agencies, advisory committees, etc.
- FDA Reviewer backgrounds and roles
- PDUFA, FDAAA and other laws and their regulations
- The importance of FDA Guidances to successful drug development
- Utilizing the Targeted Product Profile to ensure maximal patient benefit, labeling, and commercialization.
- Understanding review times and special review - implications and use (breakthrough, expedited, 505b2, accelerated approval – subpart H and E, fast track, etc.)
- Action letters and responses – what do they mean?
- Best practices of working with FDA during the drug development process
- Understanding FDA’s thinking on substantial evidence standard vs. “emerging” categories of evidence like RWE and meta-analyses
Participants may NOT receive a refund for any reason (unless LRA cancels course). If the participant cannot attend the course they may send a substitute. Course registration may be transferred to another participant at any time by notifying lucyrose01@aol.com prior to the start of the course.
Price: $750.00
REGISTER NOW
To register, please fully complete the registration form below, including checking the box agreeing to the terms, then click submit.